Hepatotoxicity-Related Adverse Effects of Proton Pump Inhibitors: A Cross-Sectional Study of Signal Mining and Analysis of the FDA Adverse Event Report System Database

Background and Objectives: Mounting evidence demonstrates that proton pump inhibitors (PPIs) are associated with a number of adverse effects. However, the literatures about hepatotoxicity-related adverse effects (HRAEs) of PPIs are mostly case reports and a few clinical studies.Methods: We evaluated...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yifan Zeng, Ying Dai, Ziye Zhou, Xuben Yu, Dawei Shi
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	proton pump inhibitors hepatotoxicity cholestasis coma hepatic hepatitis fulminant Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/93c77e2be827496cb29417409cc07d87
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:93c77e2be827496cb29417409cc07d87
record_format	dspace
spelling	oai:doaj.org-article:93c77e2be827496cb29417409cc07d872021-11-15T05:48:36ZHepatotoxicity-Related Adverse Effects of Proton Pump Inhibitors: A Cross-Sectional Study of Signal Mining and Analysis of the FDA Adverse Event Report System Database2296-858X10.3389/fmed.2021.648164https://doaj.org/article/93c77e2be827496cb29417409cc07d872021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmed.2021.648164/fullhttps://doaj.org/toc/2296-858XBackground and Objectives: Mounting evidence demonstrates that proton pump inhibitors (PPIs) are associated with a number of adverse effects. However, the literatures about hepatotoxicity-related adverse effects (HRAEs) of PPIs are mostly case reports and a few clinical studies.Methods: We evaluated the association between PPIs and HAREs using the reporting odd ratio (ROR) for mining the adverse event report signals in the FDA Adverse Event Reporting System (FAERS) database.Results: There were 23,825 reports of PPIs as primary suspect drug or second suspect drug, of which 3,253 reports were HRAEs. The top five HRAE signals caused by PPIs were hepatitis cholestatic, cholestasis, fulminant hepatitis, subacute hepatic failure, and acute hepatitis. We also summarized the signals of the HRAEs caused by each PPI. The simultaneous signals were cholestasis and hepatitis cholestatic. For the cholestasis signal, esomeprazole showed an ROR of 21.556 (95% CI 17.592–26.413); pantoprazole showed the highest ROR of 22.611 (95% CI 17.794–28.733) in the hepatic cholestatic signal; lansoprazole was the only PPI with expression in the coma hepatic signal, with an ROR of 10.424 (95% CI 3.340–32.532). By analyzing the reports of pantoprazole-induced hepatic encephalopathy, we found that patients aged over 65 years and males reported the highest rate. And from the combination of drugs and indications of drugs, no significant results were obtained.Conclusions: The RORs of signals of “cholestasis” were generally higher than those of “hepatocellular injury.” And the signals about “cholestasis” in HRAE caused by PPIs are more reported.Yifan ZengYing DaiZiye ZhouXuben YuDawei ShiFrontiers Media S.A.articleproton pump inhibitorshepatotoxicitycholestasiscoma hepatichepatitis fulminantMedicine (General)R5-920ENFrontiers in Medicine, Vol 8 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	proton pump inhibitors hepatotoxicity cholestasis coma hepatic hepatitis fulminant Medicine (General) R5-920
spellingShingle	proton pump inhibitors hepatotoxicity cholestasis coma hepatic hepatitis fulminant Medicine (General) R5-920 Yifan Zeng Ying Dai Ziye Zhou Xuben Yu Dawei Shi Hepatotoxicity-Related Adverse Effects of Proton Pump Inhibitors: A Cross-Sectional Study of Signal Mining and Analysis of the FDA Adverse Event Report System Database
description	Background and Objectives: Mounting evidence demonstrates that proton pump inhibitors (PPIs) are associated with a number of adverse effects. However, the literatures about hepatotoxicity-related adverse effects (HRAEs) of PPIs are mostly case reports and a few clinical studies.Methods: We evaluated the association between PPIs and HAREs using the reporting odd ratio (ROR) for mining the adverse event report signals in the FDA Adverse Event Reporting System (FAERS) database.Results: There were 23,825 reports of PPIs as primary suspect drug or second suspect drug, of which 3,253 reports were HRAEs. The top five HRAE signals caused by PPIs were hepatitis cholestatic, cholestasis, fulminant hepatitis, subacute hepatic failure, and acute hepatitis. We also summarized the signals of the HRAEs caused by each PPI. The simultaneous signals were cholestasis and hepatitis cholestatic. For the cholestasis signal, esomeprazole showed an ROR of 21.556 (95% CI 17.592–26.413); pantoprazole showed the highest ROR of 22.611 (95% CI 17.794–28.733) in the hepatic cholestatic signal; lansoprazole was the only PPI with expression in the coma hepatic signal, with an ROR of 10.424 (95% CI 3.340–32.532). By analyzing the reports of pantoprazole-induced hepatic encephalopathy, we found that patients aged over 65 years and males reported the highest rate. And from the combination of drugs and indications of drugs, no significant results were obtained.Conclusions: The RORs of signals of “cholestasis” were generally higher than those of “hepatocellular injury.” And the signals about “cholestasis” in HRAE caused by PPIs are more reported.
format	article
author	Yifan Zeng Ying Dai Ziye Zhou Xuben Yu Dawei Shi
author_facet	Yifan Zeng Ying Dai Ziye Zhou Xuben Yu Dawei Shi
author_sort	Yifan Zeng
title	Hepatotoxicity-Related Adverse Effects of Proton Pump Inhibitors: A Cross-Sectional Study of Signal Mining and Analysis of the FDA Adverse Event Report System Database
title_short	Hepatotoxicity-Related Adverse Effects of Proton Pump Inhibitors: A Cross-Sectional Study of Signal Mining and Analysis of the FDA Adverse Event Report System Database
title_full	Hepatotoxicity-Related Adverse Effects of Proton Pump Inhibitors: A Cross-Sectional Study of Signal Mining and Analysis of the FDA Adverse Event Report System Database
title_fullStr	Hepatotoxicity-Related Adverse Effects of Proton Pump Inhibitors: A Cross-Sectional Study of Signal Mining and Analysis of the FDA Adverse Event Report System Database
title_full_unstemmed	Hepatotoxicity-Related Adverse Effects of Proton Pump Inhibitors: A Cross-Sectional Study of Signal Mining and Analysis of the FDA Adverse Event Report System Database
title_sort	hepatotoxicity-related adverse effects of proton pump inhibitors: a cross-sectional study of signal mining and analysis of the fda adverse event report system database
publisher	Frontiers Media S.A.
publishDate	2021
url	https://doaj.org/article/93c77e2be827496cb29417409cc07d87
work_keys_str_mv	AT yifanzeng hepatotoxicityrelatedadverseeffectsofprotonpumpinhibitorsacrosssectionalstudyofsignalminingandanalysisofthefdaadverseeventreportsystemdatabase AT yingdai hepatotoxicityrelatedadverseeffectsofprotonpumpinhibitorsacrosssectionalstudyofsignalminingandanalysisofthefdaadverseeventreportsystemdatabase AT ziyezhou hepatotoxicityrelatedadverseeffectsofprotonpumpinhibitorsacrosssectionalstudyofsignalminingandanalysisofthefdaadverseeventreportsystemdatabase AT xubenyu hepatotoxicityrelatedadverseeffectsofprotonpumpinhibitorsacrosssectionalstudyofsignalminingandanalysisofthefdaadverseeventreportsystemdatabase AT daweishi hepatotoxicityrelatedadverseeffectsofprotonpumpinhibitorsacrosssectionalstudyofsignalminingandanalysisofthefdaadverseeventreportsystemdatabase
_version_	1718428567120904192

Hepatotoxicity-Related Adverse Effects of Proton Pump Inhibitors: A Cross-Sectional Study of Signal Mining and Analysis of the FDA Adverse Event Report System Database

Ejemplares similares